LONDON, Aug. 26, 2022 /PRNewswire/ -- BenevolentAI ("BenevolentAI" or the "Company") (EuronextAmsterdam:BAI), a leading, clinical-stage AI-enabled drug discovery company, will announce its interim results for the six months ended 30 June 2022 on 27 September 2022.
Read more at prnewswire.comBenevolentAI Group: Notice of Interim Results and Analyst / Investor Event
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here